New derivatives of pyridoxine exhibit high antibacterial activity against biofilm-embedded staphylococcus cells

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Kayumov, Airat R ^a   Nureeva, Aliya A ^a   Trizna, Elena Yu ^a   Gazizova, Guzel R ^a   Bogachev, Mikhail I ^b   Shtyrlin, Nikita V ^a   Pugachev, Mikhail V ^a   Sapozhnikov, Sergey V ^a   Shtyrlin, Yurii G ^a  

^a KAZAN FEDERAL UNIVERSITY   (Russian Federation)

^b SAINT PETERSBURG ELECTROTECHNICAL UNIVERSITY LETI   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

3,3,5 TRIMETHYL 8,8 DIOCTYL 1,7,8,9 TETRAHYDRO [1,3]DIOXINO[5,4 D]PYRROLO[3,4 B]PYRIDIN 8 IUM CHLORIDE; 5,6 BIS[(TRIBUTYLPHOSPHONIO)METHYL] 2,2,8 TRIMETHYL 4H [1,3]DIOXINO[4,5 C]PYRIDINE DICHLORIDE; 5,6 BIS[TRIPHENYLPHOSPHONIO(METHYL)] 2,2,8 TRIMETHYL 4H [1,3]DIOXINO[4,5 C]PYRIDINE DICHLORIDE; 5,6 BIS[TRIPHENYLPHOSPHONIO(METHYL)] 8 METHYL 2 PROPYL 4H [1,3]DIOXINO[4,5 C]PYRIDINE DICHLORIDE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BISPHOSPHONIUM SALT; CIPROFLOXACIN; MIRAMISTIN; N,N DIMETHYL N [(2,2,8 TRIMETHYL 4H [1,3]DIOXINO[4,5 C]PYRIDIN 5 YL)METHYL]OCTADECAN A AMINIUM CHLORIDE; N,N' [(2,2,8 TRIMETHYL 4H [1,3]DIOXINO[4,5C]PYRIDINE 5,6 DIYL)BIS(METHYLENE)]BIS(N,N DIMETHYLOCTAN 1 AMINIUM)DICHLORIDE; PHOSPHONIUM DERIVATIVE; PYRIDOXINE; PYRIDOXINE DERIVATIVE; QUATERNARY AMMONIUM DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BIOFILM; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANKTON; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; ANALOGS AND DERIVATIVES; CHEMISTRY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; PHYSIOLOGY;

ANTI-BACTERIAL AGENTS; BIOFILMS; PYRIDOXINE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84957084295     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/890968     Document Type: Article

References (36)

1. S. Croes, R. H. Deurenberg, M.-L. L. Boumans, P. S. Beisser, C. Neef, and E. E. Stobberingh, "Staphylococcus aureus biofilm formation at the physiologic glucose concentration depends on the S. aureus lineage," BMC Microbiology, vol. 9, article 229, 2009.
2. N. Hoiby, T. Bjarnsholt, M. Givskov, S. Molin, and O. Ciofu, "Antibiotic resistance of bacterial biofilms," International Journal of Antimicrobial Agents, vol. 35, no. 4, pp. 322-332, 2010.
3. P. Gilbert and L. E. Moore, "Cationic antiseptics: diversity of action under a common epithet," Journal of Applied Microbiology, vol. 99, no. 4, pp. 703-715, 2005.
4. W. Zimmerli and C. Moser, "Pathogenesis and treatment concepts of orthopaedic biofilminfections," FEMS Immunology and Medical Microbiology, vol. 65, no. 2, pp. 158-168, 2012.
5. J. Hurlow, K. Couch, K. Laforet, L. Bolton, D. Metcalf, and P. Bowler, "Clinical biofilms: a challenging frontier in wound care," Advances inWound Care, vol. 4, no. 5, pp. 295-301, 2015.
6. U. Romling and C. Balsalobre, "Biofilm infections, their resilience to therapy and innovative treatment strategies," Journal of Internal Medicine, vol. 272, no. 6, pp. 541-561, 2012.
7. M. R. Kiedrowski and A. R. Horswill, "New approaches for treating staphylococcal biofilm infections," Annals of the New York Academy of Sciences, vol. 1241, no. 1, pp. 104-121, 2011.
8. T. Iwase, Y. Uehara, H. Shinji et al. , "Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization," Nature, vol. 465, no. 7296, pp. 346-349, 2010.
9. M. Martins, M. Henriques, J. L. Lopez-Ribot, and R. Oliveira, "Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms," Mycoses, vol. 55, no. 1, pp. 80-85, 2012.
10. P.-H. Elchinger, C. Delattre, S. Faure et al. , "Immobilization of proteases on chitosan for the development of films with antibiofilm properties," International Journal of Biological Macromolecules, vol. 72, pp. 1063-1068, 2015.
11. H. Wu, Z. Song, M. Hentzer et al. , "Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice," Journal of Antimicrobial Chemotherapy, vol. 53, no. 6, pp. 1054-1061, 2004.
12. J. Lonn-Stensrud, M. A. Landin, T. Benneche, F. C. Petersen, and A. A. Scheie, "Furanones, potential agents for preventing Staphylococcus epidermidis biofilm infections?" Journal of Antimicrobial Chemotherapy, vol. 63, no. 2, pp. 309-316, 2009.
13. E. Yu. Trizna, E. N. Khakimullina, L. Z. Latypova et al. , "Thio derivatives of 2(5H)-furanone as inhibitors against Bacillus subtilis biofilms," Acta Naturae, vol. 7, no. 2, pp. 102-107, 2015.
14. I. L. Witso, T. Benneche, L. K. Vestby, L. L. Nesse, J. Lonn-Stensrud, and A. A. Scheie, "Thiophenone and furanone in control of Escherichia coli O103 :H2 virulence," Pathogens and Disease, vol. 70, no. 3, pp. 297-306, 2014.
15. W. Siala, M.-P. Mingeot-Leclercq, P. M. Tulkens, M. Hallin, O. Denis, and F. Van Bambeke, "Comparison of the antibiotic activities of daptomycin, vancomycin, and the investigational fluoroquinolone delafloxacin against biofilms from Staphylococcus aureus clinical isolates," Antimicrobial Agents and Chemotherapy, vol. 58, no. 11, pp. 6385-6397, 2014.
16. P. S. Stewart, W. M. Davison, and J. N. Steenbergen, "Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm," AntimicrobialAgents and Chemotherapy, vol. 53, no. 8, pp. 3505-3507, 2009.
17. G. Stone, P. Wood, L. Dixon, M. Keyhan, and A. Matin, "Tetracycline rapidly reaches all the constituent cells of uropathogenic Escherichia coli biofilms," Antimicrobial Agents and Chemotherapy, vol. 46, no. 8, pp. 2458-2461, 2002.
18. K. Forier, K. Raemdonck, S. C. De Smedt, J. Demeester, T. Coenye, and K. Braeckmans, "Lipid and polymer nanoparticles for drug delivery to bacterial biofilms," Journal of Controlled Release, vol. 190, pp. 607-623, 2014.
19. E. Lattmann, D. Kinchington, S. Dunn, H. Singh, W. O. Ayuko, and M. J. Tisdale, "Cytotoxicity of 3, 4-dihalogenated 2(5H)-furanones," Journal of Pharmacy and Pharmacology, vol. 56, no. 9, pp. 1163-1170, 2004.
20. M. Simoes, L. C. Simoes, and M. J. Vieira, "A review of current and emergent biofilmcontrol strategies," LWT: Food Science and Technology, vol. 43, no. 4, pp. 573-583, 2010.
21. M. Tischer, G. Pradel, K. Ohlsen, and U. Holzgrabe, "Quaternary ammonium salts and their antimicrobial potential: targets or nonspecific interactions?" ChemMedChem, vol. 7, no. 1, pp. 22-31, 2012.
22. L. Cheng, K. Zhang, M. A. S. Melo, M. D. Weir, X. Zhou, and H. H. K. Xu, "Anti-biofilm dentin primer with quaternary ammonium and silver nanoparticles," Journal of Dental Research, vol. 91, no. 6, pp. 598-604, 2012.
23. K. Zhang, M. A. S. Melo, L. Cheng, M. D. Weir, Y. Bai, and H. H. K. Xu, "Effect of quaternary ammoniumand silver nanoparticle-containing adhesives on dentin bond strength and dental plaque microcosm biofilms," DentalMaterials, vol. 28, no. 8, pp. 842-852, 2012.
24. M. V. Pugachev, N. V. Shtyrlin, S. V. Sapozhnikov et al. , "Bisphosphonium salts of pyridoxine: the relationship between structure and antibacterial activity," Bioorganic and Medicinal Chemistry, vol. 21, no. 23, pp. 7330-7342, 2013.
25. M. V. Pugachev, N. V. Shtyrlin, L. P. Sysoeva et al. , "Synthesis and antibacterial activity of novel phosphoniumsalts on the basis of pyridoxine," Bioorganic andMedicinal Chemistry, vol. 21, no. 14, pp. 4388-4395, 2013.
26. N. V. Shtyrlin, S. V. Sapozhnikov, S. A. Koshkin et al. , "Synthesis and antibacterial activity of novel quaternary ammonium pyridoxine derivatives," Medicinal Chemistry, vol. 11, no. 7, pp. 656-665, 2015.
27. J. Sambrook, E. F. Fritsch, and T. Maniatis, Molecular Cloning. A LaboratoryManual, Cold SpringHarbor LabPress, Cold Spring Harbor, NY, 1989.
28. A. R. Kayumov, E. N. Khakimullina, I. S. Sharafutdinov et al. , "Inhibition of biofilm formation in Bacillus subtilis by new halogenated furanones, The Journal of Antibiotics, vol. 68, no. 5, pp. 297-301, 2014.
29. G. A. OToole and R. Kolter, "Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis," Molecular Microbiology, vol. 28, no. 3, pp. 449-461, 1998.
30. B. Amorena, E. Gracia, M. Monzon et al. , "Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro," Journal of Antimicrobial Chemotherapy, vol. 44, no. 1, pp. 43-55, 1999.
31. B. Herigstad, M. Hamilton, and J. Heersink, "How to optimize the drop plate method for enumerating bacteria," Journal of Microbiological Methods, vol. 44, no. 2, pp. 121-129, 2001.
32. K. Liu, P. C. Liu, R. Liu, and X. Wu, "Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry," Medical Science Monitor Basic Research, vol. 21, pp. 15-20, 2015.
33. H. L. Bank, "Rapid assessment of islet viability with acridine orange and propidium iodide," In Vitro Cellular and Developmental Biology: Animal, vol. 24, no. 4, pp. 266-273, 1988.
34. C. A. Fux, S. Wilson, and P. Stoodley, "Detachment characteristics and oxacillin resistance of Staphyloccocus aureus biofilm emboli in an in vitro catheter infection model," Journal of Bacteriology, vol. 186, no. 14, pp. 4486-4491, 2004.
35. P. Labthavikul, P. J. Petersen, and P. A. Bradford, "In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model," Antimicrobial Agents and Chemotherapy, vol. 47, no. 12, pp. 3967-3969, 2003.
36. A. Penesyan, M. Gillings, and I. T. Paulsen, "Antibiotic discovery: combating bacterial resistance in cells and in biofilm communities," Molecules, vol. 20, no. 4, pp. 5286-5298, 2015.